Cipla | CIPLA - Interest Expense On Debt


Cipla reported INR140.3M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Arca Biopharma USD 504K 246K Sep/2024
Bio Path 130K 95K Sep/2025
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cara Therapeutics 39.02M 4.73M Sep/2025
Cipla INR 140.3M 8.5M Dec/2025
Dr.Reddys Laboratories INR 944M 37M Dec/2025
Esperion Therapeutics USD 22.64M 585K Dec/2025
Immunic 400K 400K Dec/2024
Infinity Pharmaceuticals USD 45K 0 Jun/2023
Minerva Neurosciences USD 2.31M 60K Jun/2024
Nektar Therapeutics USD 9.77M 3.75M Dec/2025
Sangamo BioSciences 97.56M 11.39M Jun/2025
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
TherapeuticsMD USD 20K 25K Sep/2023
UPL INR 7.74B 210M Dec/2025